Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Journal: Journal of Experimental Medicine
Published: 2020-02-03
DOI: 10.1084/jem.20191009
Affiliations: 6
Go to articleJournal: Journal of Experimental Medicine
Published: 2020-02-03
DOI: 10.1084/jem.20191009
Affiliations: 6
Go to article